Key Takeaways
- Embryo selection analyzes existing genetic variations in IVF, distinct from gene editing.
- Public support for embryo screening for disease is higher than for intelligence in the U.S., but equal in Singapore.
- Concerns about embryo selection include societal inequality and potential for a new form of eugenics.
- Advancements enable whole-genome sequencing and polygenic trait prediction for a wide range of conditions.
- Rigorously validating polygenic risk scores is crucial to avoid anxiety and ensure accurate health predictions.
- Pleiotropy suggests selecting against negative traits often positively impacts other desirable characteristics.
- Understanding genetic predispositions fosters compassion for human behavior and self-acceptance.
- The global landscape of embryo selection is rapidly evolving, with demand likely to drive widespread adoption.
Deep Dive
- A Harvard study found 75% of Americans support embryo screening for disease, but only 40% support it for intelligence.
- In contrast, Singapore shows equal public support for screening both disease and positive traits.
- The differing public acceptance is attributed to post-World War II taboos against ranking humans by mental characteristics, stemming from eugenics programs.
- The guest defines 'liberal eugenics' as individual reproductive choices for disease reduction, distinguishing it from governmental coercion.
- The conversation questions if selecting for traits like intelligence, defining individuality, carries a different moral weight than selecting against diseases.
- Changes in mental faculties, such as forgetfulness, are perceived as a loss of self, raising moral considerations for embryo selection.
- Pre-selecting embryos to minimize disease burden and enhance general cognitive ability could be as, or more, effective than many traditional parental investments.
- Proponents of embryo selection for traits beyond disease avoidance typically do not use language implying moral superiority of certain genetic profiles.
- Current IVF already involves some embryo selection based on morphology, though parental choice for specific traits is not yet common practice.
- While some clinics allow selection for monogenic disorders like sickle cell anemia, many restrict selection for polygenic diseases or 'neurorisk' conditions.
- The guest finds it illogical that selection based on elevated risks for conditions like breast cancer or schizophrenia is often not permitted.
- Some companies offering polygenic prediction are criticized as unreliable, akin to astrology, due to poor products and exploiting information asymmetry.
- Listeners are urged not to blindly trust company claims regarding polygenic scores for health prediction or embryo screening, given the profound implications.
- Critical validation questions include how polygenic risk scores are created, their biobank access, predictive power, and performance across different ancestry groups.
- Polygenic risk scores are derived from biobanks analyzing genetic variants associated with specific traits like schizophrenia, diabetes, or height across large populations.
- The technology simulates 500 realistic DNA recombinations for embryos, providing parents with a predictive view of potential offspring's traits and genetic risks.
- Embryo selection for intelligence could potentially yield a 15.5-point IQ spread among 10 embryos, representing a full standard deviation.
- A concern raised is that parents might feel more culpable for a child's life outcomes if they actively chose that child from a selection of embryos.
- The guest uses a polio vaccine analogy, arguing that providing later children with a technological advantage is not morally wrong, even if earlier children lacked the option.
- Actively choosing not to select against severe genetic diseases, especially when already undergoing IVF, could be considered a morally negative act.
- The field of polygenic risk scores for embryo selection is described as a new 'space race,' with companies like Herasight leading development.
- Early public reactions indicate strong interest in selecting embryos with reduced risks for common conditions like diabetes and cardiovascular disease.
- Ethical implications include 'birthers' remorse,' where parents might regret not selecting against conditions like Tay-Sachs or choosing aesthetic beauty over health.
- Pleiotropy, where a single gene influences multiple traits, raises concerns that selecting against one disease could inadvertently impact other characteristics, like IQ.
- A large-scale study analyzed thousands of genetic traits, categorizing pleiotropy into positive, neutral, and negative effects.
- The majority of pleiotropy is positive; selecting against depression can reduce risks for bipolar disorder or schizophrenia, and intelligence correlates with numerous advantageous traits.
- The guest differentiates between selecting for health and for traits like intelligence, acknowledging tension for those who are pro-choice yet support embryo selection.
- Many individuals who publicly oppose embryo selection may privately utilize it, highlighting a duality in ethical viewpoints.
- The argument that medical advancements like laser eye surgery increase stigma is critiqued, contrasting it with the perceived necessity of selecting against severe diseases.
- Recognizing genetic predispositions for behaviors like psychopathy and pedophilia may shift focus from retribution to isolation, potentially fostering greater altruism.
- The guest used ChatGPT with his genetic test results to accurately predict his personality, leading to increased compassion for others and certainty about his own inherent preferences.
- Understanding genetic predispositions can lead to greater self-acceptance and acceptance of others, contrasting with approaches like 'tiger parenting'.
- Some individuals prefer genetic editing over embryo selection as it avoids discarding embryos, sparking a debate on personhood.
- The guest argues that an embryo is an undifferentiated cell, distinct from a fetus which develops a heartbeat or brain activity over time.
- Approximately 40% of natural pregnancies spontaneously abort, often due to genetic abnormalities, which questions the moral distinction between natural and artificial selection.
- Limitations in Europe regarding embryo selection and sperm donor information are expected to reverse due to increased demand for genetic information in family planning.
- The guest predicts that China and the Middle East, with fewer moral reservations, will likely build larger biobanks and potentially subsidize IVF for polygenic trait selection.
- Widespread adoption of embryo selection is predicted in 5-10 years, with opposition expected primarily from religious extremists and certain segments of the left.